Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 12-2023 | 06-2023 | 12-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,171 | 2,528 | 5,905 | 2,930 | 4,168 |
| Other Operating Activity | -11,519 | -5,142 | -12,451 | -6,963 | -8,274 |
| Operating Cash Flow | $-6,348 | $-2,614 | $-6,546 | $-4,033 | $-4,106 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22 | -18 | -12 | -2 | -46 |
| Net Acquisitions | 0 | N/A | -327 | -320 | -2,467 |
| Other Investing Activity | 97 | 77 | 129 | 53 | 2 |
| Investing Cash Flow | $75 | $59 | $-210 | $-269 | $-2,511 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,851 | -114 | 3,985 | -110 | -202 |
| Financing Cash Flow | $1,851 | $-114 | $3,985 | $-110 | $-202 |
| Exchange Rate Effect | -58 | -16 | 158 | 14 | 166 |
| Beginning Cash Position | 5,149 | 5,116 | 7,898 | 7,716 | 15,165 |
| End Cash Position | 669 | 2,430 | 5,285 | 3,318 | 8,511 |
| Net Cash Flow | $-4,480 | $-2,686 | $-2,612 | $-4,397 | $-6,654 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,348 | -2,614 | -6,546 | -4,033 | -4,106 |
| Capital Expenditure | N/A | -18 | N/A | N/A | N/A |
| Free Cash Flow | -6,348 | -2,633 | -6,546 | -4,033 | -4,106 |